McGrath, Arlene
20  results:
Search for persons X
?
 
?
2

P43 Patient tolerability of adalimumab biosimilar therapy i..:

McGuire, Arlene ; Guard, Sarah ; Topping, Karen...
British Journal of Dermatology.  188 (2023)  Supplement_4 - p. , 2023
 
?
4

Experiential Value of Technologies: A Qualitative Study wit..:

Desai, Shital ; McGrath, Colleen ; McNeil, Heather...
International Journal of Environmental Research and Public Health.  19 (2022)  4 - p. 2235 , 2022
 
?
5

A Protocol Paper on the Preservation of Identity: Understan..:

McGrath, Colleen ; Molinaro, Monica L. ; Sheldrake, Elena J...
International Journal of Qualitative Methods.  18 (2019)  - p. 160940691983183 , 2019
 
?
7

Investigating the enabling factors influencing occupational..:

McGrath, Colleen ; Ellis, Maggie ; Harney-Levine, Sarah...
British Journal of Occupational Therapy.  80 (2017)  11 - p. 668-675 , 2017
 
?
8

The benefits and barriers to technology acquisition: Unders..:

McGrath, Colleen ; Astell, Arlene
British Journal of Occupational Therapy.  80 (2016)  2 - p. 123-131 , 2016
 
?
9

BS4-3 Can mitochondrial mutations help explain the high inc..:

McGrath, Nicole ; Savage, Amy ; Allen, Liz.
Diabetes Research and Clinical Practice.  79 (2008)  - p. S17-S18 , 2008
 
?
 
?
11

A scoping review to inform the development of dementia care..:

Kay, Kelly ; Metersky, Kateryna ; Smye, Victoria...
https://centaur.reading.ac.uk/110981/9/14713012231165568.pdf.  , 2023
 
?
 
?
15

The benefits and barriers to technology acquisition: unders..:

McGrath, Colleen ; Astell, Arlene
https://centaur.reading.ac.uk/96105/1/FINAL%20OA%27s%20Adoption%20of%20LVADs%20BJOT%20July%2012,%202016%20CLEAN%20COPY.pdf.  , 2017
 
1-15